Clinical trial of SR-16234 in patients with endometriosis.
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2017
At a glance
- Drugs SR 16234 (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- 03 Apr 2017 Status changed from active, no longer recruiting to completed.
- 03 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 01 Oct 2015 Status changed from planning to not yet recruiting, as reported by University Hospital Medical Information Network - Japan.